UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 12 | December 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 8
August-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2308141


Registration ID:
522219

Page Number

b319-b346

Share This Article


Jetir RMS

Title

DEVELOPMENT & EVALUATION OF MATRIX RELEASE TABLET OF TELMISARTAN FOR THE TREATMENT OF HYPERTENSION

Authors

Abstract

Dosage forms are what transport drug molecules to the specific areas in the body where they are needed to work. It is best to use inhalation treatment to get the most out of your medication. Example Inhalants, Fluid dosage forms for drugs that dissolve in water or any other liquid medium. Explanation-Solution.[1] Ensure that medication can be injected into the body's orifices. Rectal and vaginal suppositories, as an illustration. When there is only a small amount of the active component, it is required to use a lubricant in order to prevent the tablet from sticking to the machine. A disintegrator such as starch expands when it comes into touch with fluids in the stomach, which makes it easier for the tablet to break apart.[4] Various oral extended-release dose forms, such as sustained action, delayed release, lengthy action, and retarded release, sustained release, prolonged action, were originally referred to as "modified release dosage products.

Key Words

NDDS, Telmisartan, Drug delivery, Dosage form

Cite This Article

"DEVELOPMENT & EVALUATION OF MATRIX RELEASE TABLET OF TELMISARTAN FOR THE TREATMENT OF HYPERTENSION", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 8, page no.b319-b346, August-2023, Available :http://www.jetir.org/papers/JETIR2308141.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"DEVELOPMENT & EVALUATION OF MATRIX RELEASE TABLET OF TELMISARTAN FOR THE TREATMENT OF HYPERTENSION", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 8, page no. ppb319-b346, August-2023, Available at : http://www.jetir.org/papers/JETIR2308141.pdf

Publication Details

Published Paper ID: JETIR2308141
Registration ID: 522219
Published In: Volume 10 | Issue 8 | Year August-2023
DOI (Digital Object Identifier):
Page No: b319-b346
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000198

Print This Page

Current Call For Paper

Jetir RMS